C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Alsonex Pty Ltd
ChemoCentryx Inc
Dompe Farmaceutici SpA
InflaRx NV
Innate Pharma SA
MorphoSys AG
Prommune Inc
Teva Pharmaceutical Industries Ltd
Visterra Inc